We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SPRY

Price
14.85
Stock movement up
+0.23 (1.57%)
Company name
Silverback Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.44B
Ent value
1.42B
Price/Sales
568.64
Price/Book
7.18
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
68.75%
3 year return
64.11%
5 year return
-
10 year return
-
Last updated: 2025-05-29

DIVIDENDS

SPRY does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales568.64
Price to Book7.18
EV to Sales559.56

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count97.19M
EPS (TTM)-0.51
FCF per share (TTM)-0.48

Income statement

Loading...
Income statement data
Revenue (TTM)2.54M
Gross profit (TTM)2.38M
Operating income (TTM)-60.51M
Net income (TTM)-49.10M
EPS (TTM)-0.51
EPS (1y forward)-0.36

Margins

Loading...
Margins data
Gross margin (TTM)93.97%
Operating margin (TTM)-2384.00%
Profit margin (TTM)-1934.75%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash39.66M
Net receivables773.00K
Total current assets208.79M
Goodwill0.00
Intangible assets7.50M
Property, plant and equipment1.11M
Total assets217.60M
Accounts payable8.28M
Short/Current long term debt102.00K
Total current liabilities16.62M
Total liabilities16.62M
Shareholder's equity200.98M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-45.86M
Capital expenditures (TTM)352.00K
Free cash flow (TTM)-46.21M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-24.43%
Return on Assets-22.57%
Return on Invested Capital-24.42%
Cash Return on Invested Capital-22.98%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open14.56
Daily high14.85
Daily low14.32
Daily Volume961K
All-time high60.41
1y analyst estimate26.50
Beta1.00
EPS (TTM)-0.51
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SPRYS&P500
Current price drop from All-time high-75.42%-4.11%
Highest price drop-95.20%-56.47%
Date of highest drop11 May 20229 Mar 2009
Avg drop from high-77.48%-11.06%
Avg time to new high54 days12 days
Max time to new high1055 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SPRY (Silverback Therapeutics Inc) company logo
Marketcap
1.44B
Marketcap category
Small-cap
Description
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Employees
24
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...